CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 82 filers reported holding CARA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,299 | -54.9% | 44,821 | -24.0% | 0.00% | – |
| Q2 2023 | $166,806 | -51.8% | 58,942 | -16.4% | 0.00% | – |
| Q1 2023 | $346,327 | -56.5% | 70,535 | -4.8% | 0.00% | -100.0% |
| Q4 2022 | $795,727 | +16.2% | 74,090 | +1.3% | 0.00% | – |
| Q3 2022 | $685,000 | -4.9% | 73,133 | -7.3% | 0.00% | -100.0% |
| Q2 2022 | $720,000 | -31.4% | 78,867 | -8.7% | 0.00% | 0.0% |
| Q1 2022 | $1,049,000 | +5.4% | 86,370 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $995,000 | +46.1% | 81,716 | +85.3% | 0.00% | – |
| Q3 2021 | $681,000 | +44.0% | 44,109 | +33.0% | 0.00% | – |
| Q2 2021 | $473,000 | +240.3% | 33,173 | +417.0% | 0.00% | – |
| Q1 2021 | $139,000 | -45.7% | 6,417 | -62.0% | 0.00% | – |
| Q4 2020 | $256,000 | +62.0% | 16,908 | +36.1% | 0.00% | – |
| Q3 2020 | $158,000 | -57.4% | 12,426 | -42.6% | 0.00% | – |
| Q2 2020 | $371,000 | +6.9% | 21,659 | -17.3% | 0.00% | – |
| Q1 2020 | $347,000 | -62.7% | 26,204 | -54.7% | 0.00% | – |
| Q4 2019 | $931,000 | -49.8% | 57,830 | -42.9% | 0.00% | -100.0% |
| Q3 2019 | $1,853,000 | -50.9% | 101,361 | -42.2% | 0.00% | -66.7% |
| Q2 2019 | $3,772,000 | +198.2% | 175,448 | +172.1% | 0.00% | +200.0% |
| Q1 2019 | $1,265,000 | -71.8% | 64,476 | -81.3% | 0.00% | -75.0% |
| Q4 2018 | $4,489,000 | +14.3% | 345,296 | +110.7% | 0.00% | 0.0% |
| Q3 2018 | $3,927,000 | +157.2% | 163,918 | +105.5% | 0.00% | +100.0% |
| Q2 2018 | $1,527,000 | +63.5% | 79,765 | +5.7% | 0.00% | – |
| Q1 2018 | $934,000 | +33.8% | 75,453 | +32.2% | 0.00% | – |
| Q4 2017 | $698,000 | -8.5% | 57,061 | +2.2% | 0.00% | -100.0% |
| Q3 2017 | $763,000 | +74.2% | 55,818 | +96.2% | 0.00% | – |
| Q2 2017 | $438,000 | +3028.6% | 28,444 | +3642.6% | 0.00% | – |
| Q1 2017 | $14,000 | +180.0% | 760 | +48.4% | 0.00% | – |
| Q4 2016 | $5,000 | +25.0% | 512 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -55.6% | 512 | -72.5% | 0.00% | – |
| Q2 2016 | $9,000 | -93.3% | 1,862 | -91.4% | 0.00% | – |
| Q1 2016 | $134,000 | -18.3% | 21,633 | +122.7% | 0.00% | – |
| Q4 2015 | $164,000 | +811.1% | 9,714 | +652.4% | 0.00% | – |
| Q3 2015 | $18,000 | -52.6% | 1,291 | -58.6% | 0.00% | – |
| Q2 2015 | $38,000 | -93.2% | 3,119 | -94.4% | 0.00% | -100.0% |
| Q1 2015 | $558,000 | +3.0% | 55,561 | +2.2% | 0.00% | – |
| Q4 2014 | $542,000 | +27000.0% | 54,367 | +28818.6% | 0.00% | – |
| Q3 2014 | $2,000 | +100.0% | 188 | +213.3% | 0.00% | – |
| Q2 2014 | $1,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |